Latest Headlines

31. CDMO Made Scientific Opens New Cell Therapy Manufacturing Facility In New Jersey 8/14/2025

    Made Scientific, a leading U.S.-based cell therapy contract development and manufacturing organization (CDMO), held a ribbon-cutting ceremony yesterday to commemorate the grand opening of its new 60,000 sq. ft. GMP manufacturing facility and headquarters in Princeton, New Jersey.

32. AST Names Industry Veteran Jacob Stephen As Chief Operating Officer 8/13/2025

    AST is pleased to announce that Jacob Stephen will be joining the AST Team as Chief Operations Officer at the Tacoma-headquartered drug product equipment manufacturing company. Stephen joins AST from IPS, where he most recently served as Head of Operations for the Americas.

33. Pace® Life Sciences Debuts Enhanced cGMP Manufacturing Capabilities To Support Increasing Demand For Sterile Injectables 8/12/2025

    Pace^® Life Sciences, a U.S.-based CRDMO and full-service FDA-registered GMP Analytical Testing laboratory re-opened its 33,000 square foot facility in Salem, NH with advanced technologies to support small batch manufacturing.

34. Advancing Countermeasures Against Ebola And Deadly Viruses 8/12/2025

    Asimov, the synthetic biology company advancing the design and manufacture of therapeutics, has been selected by BARDA's Biopharmaceutical Manufacturing Preparedness Consortium (BioMaP-Consortium) to lead a project focused on "Manufacturing Optimization for Filovirus Human Monoclonal Antibodies."

35. Repligen Opens Training & Innovation Center To Elevate Customer Experience 8/7/2025

    Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced the grand opening of its Repligen Training & Innovation Center (“RTIC”) at its Waltham headquarters.

36. Minaris Advanced Therapies Opens New Manufacturing Facility In Germany 8/6/2025

    Minaris Advanced Therapies, a leading global contract development and manufacturing organization and testing provider, has announced the opening of its new GMP manufacturing facility in Munich, Germany.  The facility, located in Taufkirchen, strengthens Minaris' global manufacturing network and reinforces its position as a trusted partner in advancing cutting-edge therapies from concept to commercialization.

37. Invetech And AiCella Announce Strategic Collaboration To Advance Cell Therapy Innovation 7/18/2025

    Invetech, a global leader in solving complex manufacturing and product development challenges in the advanced therapies and diagnostics markets, today announced a strategic collaboration with AiCella, a company focused on harnessing the power of artificial intelligence (AI) to optimize the development of cell therapy production processes and maximize patient response to treatment.

38. Meet Avance Clinical At 2025 KoNECT-MOHW-MFDS International Conference (KIC) 7/15/2025

    This prestigious conference is a premier platform for biotech and pharma companies to explore emerging trends, regulatory developments, and innovations shaping the future of clinical trials across Asia and around the world.

39. Meet Avance Clinical At BIO Asia-Taiwan 2025 7/15/2025

    This year’s program features Business Partnering, Exhibitions, and Conferences, offering insights into emerging bio-health trends, technologies, and global expansion strategies. Our team is looking forward to connecting with biotech leaders in Taiwan to discuss tailored solutions across the drug development lifecycle.

40. Bispecific Antibody Produced Using CHO Edge Expression System 7/9/2025

    Asimov, the synthetic biology company advancing the design and manufacture of therapeutics, announced the clearance of an Investigational New Drug (IND) application by the U.S. Food and Drug Administration (FDA) for a bispecific antibody produced using its CHO Edge expression system.